American Society of Hematology

Figure 3.

$Figure 3. Flow cytometry of progenitor and endothelial markers. Percentage of CD34+, KDR+, and VWF+ HUVECs (▦) and EPCs (▪) from the mononuclear cell fraction of human peripheral blood. EPCs were treated for 24 hours with ABRM (▨) from HUVECs. IgG-FITC antibody was used as a control (CON). Mean ± SD, n = 4, *P < .05.$

Flow cytometry of progenitor and endothelial markers. Percentage of CD34⁺, KDR⁺, and VWF⁺ HUVECs (▦) and EPCs (▪) from the mononuclear cell fraction of human peripheral blood. EPCs were treated for 24 hours with ABRM (▨) from HUVECs. IgG-FITC antibody was used as a control (CON). Mean ± SD, n = 4, ^*P < .05.

This Feature Is Available To Subscribers Only